VU0364770
Cat. No.:YN320056
CAS No. :61350-00-3
产品名称: | VU0364770 |
CAS No.: | 61350-00-3 |
Chemical Name: | N-(3-chlorophenyl)-2-pyridinecarboxamide |
Synonyms: | VU 0364770 |
分子量: | 232.67 |
分子式: | C₁₂H₉ClN₂O |
SMILES: | O=C(C1=NC=CC=C1)NC2=CC=CC(Cl)=C2 |
存储: | Please store the product under the recommended conditions in theCertificate of Analysis. |
运输: | Room temperature in continental US; may vary elsewhere. |
产品描述: | VU0364770 是一种有效的选择性mGlu4正变构调节剂 (PAM)。VU0346770 对大鼠 mGlu4 和人 mGlu4 受体的EC50分别为 290 nM 和 1.1 μM。VU0364770 对 mGlu5 具有拮抗活性,EC50为 17.9 μM,VU0364770 对 mGlu6 具有正变构调节活性,EC50为 6.8 μM。VU0364770 还对 MAO 具有活性,作用于人 MAO-A 和 MAO-B 的 Ki值分别为8.5 和 0.72 μM。 |
IC50和靶点: | [{name:"Rat mGlu4:290 nM (EC50)"},{name: "Human mGlu4:1.1 μM (EC50)"},{name: "mGlu6:6.8 μM (EC50)"},{name: "mGlu5:17.9 μM (EC50)"}] |
In Vitro: | |
In Vivo: | |
Clinical Trial: | |
Solvent & Solubility: |
Jones, C.K., Bubser, M., Thompson, A.D., et al.The metabotropic glutamate receptor 4-positive allosteric modulator VU0364770 produces efficacy alone and in combination with ʟ-DOPA or an adenosine 2A antagonist in preclinical rodent models of Parkinson's diseaseJ. Pharmacol. Exp. Ther.340(2),404-421(2012)